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A B S T R A C T
There is a continuing rise in the occurrence of multidrug-resistant bacterial infections. Antibiotic resistance to currently available antibiotics has become a global
health issue leading to an urgent need for alternative antibacterial strategies. There has been a renewed interest in the development of antibacterial agents from
natural sources, and trans-cinnamaldehyde is an example of a naturally occurring compound that has received significant attention in recent years. Trans-
Cinnamaldehyde has been shown to possess substantial antimicrobial activity, as well as an array of other medicinal properties, and represents an intriguing hit
compound from which a number of derivatives have been developed. In some cases, these derivatives have been shown to possess improved activity, not only
compared to trans-cinnamaldehyde but also to commonly used antibiotics. Therefore, understanding the antibacterial mechanisms of action that these compounds
elicit is imperative in order to facilitate their development and the development of new antibacterial agents that could exploit similar mechanistic approaches. The
purpose of this review is to provide an overview of current knowledge on the antibacterial activity and mechanisms of action of cinnamaldehyde and its derivatives,




Antibiotics and antimicrobial agents are those substances that in-
hibit the growth of bacteria, with many disrupting vital cellular func-
tions thereby causing rapid bacterial cell death [1]. In the last forty
years, antibiotics have been over-used by humans, not only by direct
consumption but also through their extensive use in animal feed [2].
Consequentially, antibiotic resistance in several pathogenic organisms
has occurred [2], with a corresponding reduction in the efficacy of
antibiotics that are currently on the market, and has now resulted in
antibiotic resistance becoming a global health issue [1]. The American
Center for Disease Control and Prevention has reported that more than
two million diseases have been caused by microorganisms that are re-
sistant to more than one class of antibiotics [3]. Antibiotic resistance
also causes a substantial economic burden, incurring approximately
€1.5 billion in additional health care costs within the European Union
[1]. Moreover, this resistance has a high associated mortality rate.
Based on data collected between January 1st 2015 and December 31st
2015, it is estimated that infections involving antibiotic-resistant bac-
teria accounted for 33,110 attributable deaths in the EU and EEA
(European Economic Area) [4]. This high mortality rate is due to the
fact that these related infections have become extremely difficult to
treat, where examples include extensively drug-resistant tuberculosis
(XDR-TB) and community-associated methicillin-resistant Staphylo-
coccus aureus (MRSA). Such infections pose a monumental challenge to
clinicians [2].
1.2. Natural products
Aside from the emergence of bacterial antibiotic resistance, negative
consumer attitudes toward synthetic food preservatives has meant that
the use of natural products, such as plant components containing es-
sential oils and essences, for the purposes of prevention of food spoilage
and protection from harmful pathogens has gained increasing consumer
popularity [5,6]. This consumer trend is in part due to perceived nu-
tritional and safety qualities of natural products [7–9]. As a result, there
has been renewed interest by food scientists in the use of spices and
natural preservatives derived from plant sources as alternative anti-
microbial agents [7,8]. Historically, plants, spices, and their essential
oils have been used in traditional medicine [10]. From an ecological
viewpoint, the use of plants as a source of antimicrobial agents is a
sensible strategy because plants naturally produce an array of sec-
ondary metabolites that defend the host from microbiological invasion
[3,6]. In addition, plants can contain chemical entities that have diverse
features such as complex structures that synthetically would be difficult
to obtain. This may enable these natural antibacterials to elicit different
mechanisms of action compared to traditional antibacterial agents [3].
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1.3. Cinnamon as a natural product
Cinnamon spice is obtained from the inner bark of several trees
within the genus Cinnamomum, which itself is comprised of approxi-
mately 250 plant species [11,12]. The most common species are C.
cassia (Chinese cinnamon, commonly referred to as Cassia) and C.
verum (also called C. zeylanicum, commonly referred to as true cin-
namon). These two species contain a varying percentage of cinna-
maldehyde with up to 85.3% and 90.5% reported, respectively [11].
trans-Cinnamaldehyde has been identified as the component that gives
rise to much of the reported antimicrobial properties of this spice
[9,12–16]. Isolated cinnamaldehyde has been shown to effectively in-
hibit the growth of an array of microorganisms such as bacteria,
moulds, and yeasts, as well as having been reported to inhibit toxin
production by micro-organisms [8,9,13,17,18].
1.4. Commercial use of trans-cinnamaldehyde
trans-Cinnamaldehyde is Generally Recognized as Safe (GRAS) by
the United States Food and Drug Administration (FDA), and Flavour
and Extract Manufacturer's Association (FEMA), and has been granted A
status (i.e. may be used in foodstuffs) by the Council of Europe [17]. On
this basis, trans-Cinnamaldehyde can be viewed as a safe food and
flavour additive, with a pleasant taste and odour, and has found many
commercial food uses [15,17]. Cinnamon has been a useful spice since
biblical times, when it was utilized as a perfume in rubbing oils [11].
Egyptians employed cinnamon as a fragrance for preserving bodies [11]
and more recently, trans-cinnamaldehyde has been used agriculturally
as a fungicide [19]. Cinnamaldehyde has also been incorporated into
edible antimicrobial films, prepared from foodstuffs such as fruit and
vegetables, and has inactivated foodborne pathogens either by direct
contact or by vapours released from the films in closed containers [20].
These films have also been shown to reduce the presence of non-pa-
thogenic spoilage organisms that impact food quality [17]. This cor-
relates with a growing interest in natural antimicrobials that not only
prevent the growth of foodborne pathogens and spoilage microorgan-
isms, but can also enhance the flavour and quality of foods [21]. Thus,
in light of trans-cinnamaldehyde being a safe additive that is already
being added to foods to enhance flavour, related cinnamaldehyde de-
rivatives have the potential to be cost-effective, food-compatible,
broad-spectrum antimicrobial additives that could be used against an
array of pathogenic micro-organisms [17], and hence have sparked the
Fig. 1. Examples of cinnamaldehyde derivatives from the literature that have reported medicinal properties, a denotes a naturally occurring cinnamaldehyde, b
denotes a synthetic cinnamaldehyde derivatives.
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interest of researchers across the globe.
1.5. Limitations of trans-cinnamaldehyde for commercial applications
There have been some undesirable aspects reported for trans-cin-
namaldehyde that has limited its commercial use. For one, the solubi-
lity of this compound in water is low at approximately 1.1 g/L at 20 °C
[19]. It is also sensitive when exposed to light and air for prolonged
periods [19]. In vivo, it is possible that trans-cinnamaldehyde decom-
poses to cinnamic acid by enzyme catalysis before it is able to elicit its
antibacterial activity, hence could be considered unstable in blood [12].
Additionally, J. Visvalingham et al. [9] were the first to show that Es-
cherichia coli (E. coli) O157:H7 can convert cinnamaldehyde to cin-
namic alcohol using dehydrogenase/reductase enzymes [9]. Cinna-
maldehyde is a known sensitizer in humans and the North American
Contact Dermatitis Research group have reported that cinnamaldehyde
is a frequent cause of allergic reactions as a constituent of perfumes and
cosmetics [11]. In human dermatological studies, the No-Observed-
Adverse-Effect-Level (NOAEL) for cinnamaldehyde sensitization has
been set at 0.5% [11]. For this reason, the International Fragrance
Research Association (IFRA) has limited its use to 0.05% [11]. Thus,
this highlights the need for research into cinnamaldehyde derivates that
have lower sensitization effects, lower toxicity, but improved anti-
bacterial activity to that of trans-cinnamaldehyde.
2. General medicinal properties of cinnamaldehyde and its
derivatives
Extensive research has been carried out investigating the broad
scope of medicinal applications associated with cinnamaldehyde and its
natural and synthetic derivatives. A number of excellent reviews have
been published with respect to the medicinal properties associated with
trans-cinnamaldehyde itself (Fig. 1, structure 1) [12,17,19], as well as
reviews on cinnamaldehyde derivatives and their associated medicinal
properties including noteworthy examples by Chen et al. [22] and
Shreaz et al. [11]. The following section will discuss a number of
medicinal applications for which cinnamaldehyde and its derivatives
have been studied. Other applications for trans-cinnamaldehyde in-
cluding anti-mold, anti-diabetes, neuroprotective, and anti-oxidant
functions, have all been discussed previously in the literature [22–24].
2.1. Anticancer/antitumour activity
One such medicinal application discussed in depth is the use of
trans-cinnamaldehyde, as well as its derivatives, as potential anti-tu-
mour and anti-cancer agents. Trans-Cinnamaldehyde has been shown to
be active against a number of cancer cell lines, including A549 lung, SK-
OV-3 ovarian, and XF-498 central nerve system cell lines [25]. In ad-
dition, cinnamaldehyde has been reported to significantly inhibit NNK
(4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone) induced pulmonary
carcinogenesis in vivo in rasH2 male mice [26]. Notably, trans-cinna-
maldehyde exhibited comparable activity to anticancer agents such as
cisplatin with respect to HeLa epithelioid cervix, SK-MEL-2 melanoma,
and HCT-15 colon tumour cells [25]. With respect to its demonstrated
ability to inhibit human hepatoma PLC/PRF/5 cell proliferation, cin-
namaldehyde has also been shown to cause the cell cycle to arrest in the
S phase and to induce apoptosis by activating pro-apoptotic Bcl-2 fa-
mily proteins, namely Bax and Bid, as well as activating the MAPK
(mitogen-activated protein kinases) signalling pathway [27].
A number of synthetic cinnamaldehyde derivatives including 2-
benzoyloxycinnamaldehyde, 4-hydroxycinnamaldehyde, 2-hydroxy-5-
fluorocinnamaldehyde, CB403 and a number of synthesized dimer
analogues as well as naturally-occurring 2-hydroxycinnamaldehyde and
2-methoxycinnamaldheyde (Fig. 1, structure 2–7) have demonstrated
anti-cancer properties against a range of cancer cell lines. These include
human leukemic, oral carcinoma, prostate and colon cancer cell lines
[28–31], with their mechanisms of action having been investigated in
some cases (Fig. 1, structure 8–11) [23,28–37]. Cabello et al. [38] in-
vestigated the effect of not only the naturally occurring trans-cinna-
maldehyde and cinnamic acid, but also a range of synthetic cinna-
maldehyde derivatives on melanoma cell proliferation, invasiveness,
and tumour growth [38] and found that Michael acceptor ability was
important for activity, as discussed later in section 3.0. A similar finding
was observed in other bioactivity assays, including that conducted by
Motohashi et al. [39] who have evaluated the structure–activity re-
lationship of antimutagenic benzalacetone (Fig. 1, structure 12) and its
related compounds, also discussed later in section 3.0 [39]. Jeong et al.
[40] synthesized a range of cinnamaldehyde derivatives in order to
identify their anti-tumour mechanism of action and characterised these
compounds as cyclin dependent kinases (CDK)4 inhibitors. Research in
this area has placed a focus on cyclin D1-CDK4 complexes as there is
growing evidence that its activity is vital for proliferation of many tu-
mours [40]. Synthesized (E)-3-benzoyloxycinnamaldehyde was found
to possess the greatest activity of those trans-cinnamaldehydes eval-
uated by Jeong et al. [40].
2.2. Cardioprotection function
The cardioprotection and related activity of cinnamaldehyde and its
derivatives has also been studied. X.-Q Li et al. [41] assessed the
therapeutic effects of cinnamaldehyde and five derivatives on viral
myocarditis (VMC). Here, synthetic derivatives α-bromo-4-methylcin-
namaldehyde and α-bromo-4-chlorocinnamaldehyde (Fig. 1, structure
13) showed considerable inhibition of CVB3 replication and CVB3-in-
duced cardiac injury both in vitro and in vivo. These two derivatives
showed improved anti-vital and anti-inflammatory activity, as well as
lower toxicity relative to cinnamaldehyde. Song et al. [42] demon-
strated that cinnamaldehyde exhibited cardioprotective effects against
acute ischemic myocardial injury induced by isoproterenol in rats. The
authors suggest that its anti-oxidative and anti-inflammatory proper-
ties, as well as its ability to elevate nitric oxide levels, might have
contributed to its observed cardioprotective properties. Similar effects
have been observed with respect to naturally occurring 2-methox-
ycinnamaldheyde (Fig. 1, structure 7) [43]. The vasodilatory properties
of cinnamaldehyde have also been established and it has been indicated
that such properties are attributable to cinnamaldehyde's ability to in-
terfere with Ca2+ influx and release [23,44].
2.3. Cinnamaldehyde and derivatives as anti-inflammatory agents
The potential of trans-cinnamaldehyde and its derivatives as anti-
inflammatory agents has also been reported. Nuclear factor (NF)-κB is a
transcription factor that regulates the expression of inflammatory and
immune genes. Reddy et al. [45] identified trans-cinnamaldehyde and
naturally occurring 2-methoxycinnamaldehdye (Fig. 1, structure 1 & 7)
as NF-κB inhibitors, which were shown not only to inhibit its tran-
scriptional activity but also to inhibit its lipopolysaccharide (LPS)-in-
duced DNA binding in a dose-dependent manner. Guo et al. [46]
showed that cinnamaldehyde inhibits interleukin (IL)-1β-induced
prostglandin E2 (PGE2) production by inhibiting cyclooxygenase (COX)-
2 activity. This was demonstrated using cultured rat cerebral micro-
vascular endothelial cells (RCMEC). Both IL-1β and PGE2 are associated
with causing fevers. Liao et al. [47] investigated the anti-inflammatory
effects of cinnamaldehyde and suggested that its mechanism of action
may relate to its ability to inhibit the protein expression of inducible
nitric oxide synthase (iNOS), in addition to increasing the activities of
antioxidant enzymes catalase, superoxide dismutase, and glutathione
peroxidase [47]. Kwon et al. [48] similarly demonstrated that synthetic
2-benzoyloxycinnamaldehyde (Fig. 1, structure 2) inhibited the LPS-
induced NO production and iNOS expression, doing so without af-
fecting cell proliferation or causing cytotoxicity. Its mode of action was
identified as the inhibition of JNK activation and subsequent AP-1
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activation. Thus, 2-benzoyloxycinnamaldehyde has been suggested as a
promising candidate for the treatment of inflammation-related disease
[48]. Rao et al. [23] also discussed the evaluation of naturally-occur-
ring 2′-hydroxycinnamaldehyde (Fig. 1, structure 6) as a potential anti-
inflammatory agent, by the inhibition of NO production via reducing
the activation of NF-??B.
2.4. Antifungal activity
The antifungal properties of cinnamaldehyde and its derivatives is
well established. Cinnamaldehyde and its derivatives have been have
been screened against several pathogenic fungi and shown to exhibit
antifungal activity against Aspergillus flavus [49,50], Aspergillus fumi-
gatus and Trichophyton rubrum [51], Coriolus versicolor and Laetiporus
sulphurous [52], Aspergillus ochraceus as well as its associated toxins
[53,54], and Candida spp including some fluconazole-resistant strains
[55,56]. Interestingly, cis-cinnamaldehyde, the geometrical isomer of
trans-cinnamaldehyde, has also been shown to possess antifungal
properties [57]. There are numerous reported investigations into cin-
namaldehyde and its derivatives as antifungal agents, with Shreaz et al.
[11] having published an excellent review on this topic in 2016. They
note that cinnamaldehyde itself is interesting as a potential antifungal
agent because, aside from the extensive antifungal activity it exhibits, it
can potentially overcome some of the drawbacks of current antifungal
chemotherapy. This is in light of its rapid and irreversible in vitro ac-
tivity against several fluconazole-resistant Candida strains, with no as-
sociated toxicity being observed against H9c2 cells and human RBCs
[55,56]. They also affirm the potential of cinnamaldehyde derivatives
as alternatives to current antifungal treatments, highlighting the sig-
nificant activity of such cinnamaldehyde synthetic derivatives as
2(−bromo-cinnamaldehyde) (Fig. 1, structure 14), 2(−chloro-cinna-
maldehyde), α-methyl cinnamaldehyde, as well as a range of amino
acid-based adducts of cinnamaldehyde [58], and naturally-occurring
derivatives o-methoxy cinnamaldehyde (Fig. 1, structure 7) [59,60],
coniferyl aldehyde and sinapaldehyde (Fig. 1, structures 15 & 16)
[56,61]. Interestingly, commercial cinnamon preparations containing
trans-cinnamaldehyde and o-methoxycinnamaldehyde also gave relief
to three out of five HIV patients with oral candidiasis [62].
2.5. Thermogenic effects
Studies by Jiang et al. [63] have indicated that cinnamaldehyde
activates thermogenic responses in both mice and humans. This is
evidenced by several results. For example, post-treatment with 400 μM
cinnamaldehyde resulted in the up regulation of thermogenic genes and
activation of PKA signalling. This is significant as PKA activation is a
large component of the classical pathway for the activation of ther-
mogenesis in adipocytes. Cinnamaldehyde was also shown to activate
metabolic responses. For example, after administration of 200 μM cin-
namaldehyde the authors observed the upregulation in expression of (i)
lipolytic genes Hsl and Atg, (ii) key regulators in fatty acid oxidation
Cpt1b and Ppara, and (iii) the enzyme Pdk4 that increases lipid meta-
bolism and has been reported to be attributed to major metabolic
adaptations during white-to-beige conversion of human adipocytes. Not
only were thermogenic and metabolic responses shown to be activated
in mouse and human primary subcutaneous adipocytes in response to
cinnamaldehyde, but the results of this study suggest that this is done in
a cell-autonomous manner. This is important as it gives a plausible
mechanistic explanation for the anti-obesity effects of cinnamaldehyde
that has been observed in previous studies [64,65]. In addition, it fur-
ther supports its potential metabolic benefits on humans, an important
observation given the wide usage of cinnamaldehyde commercially,
particularly with respect to the food industry where it is commonly
used as a food additive [63].
Masamoto et al. [66] also found that cinnamaldehyde enhanced
thermogenesis and inhibited heat diffusion. This was deduced on the
basis that the administration of cinnamaldehyde (50mg/kg of body
weight) to 7-week-old male mice of the C57BL/6 strain increased both
colonic temperature (by approximately Δ+0.7 °C after 240min) and
intrascapular brown adipose tissue temperature (by approximately
Δ+0.9 °C after 240min). Throughout the 240-min period, the control
group changed by approximately Δ+0.1 °C and Δ+0.05 °C, respec-
tively. Exposure to cinnamaldehyde did not increase the tail-skin tem-
perature, conversely it decreased the tail skin temperature but only by
approximately Δ-0.175 °C after 200–240min. The control group
showed a slight increase by approximately Δ+0.175 °C during this
timeframe. Overall, the results of this study suggest that thermo-
sensitive transient receptor potential channels (thermoTRPs) could play
a role in controlling autonomic thermoregulation [66].
In a study by Iwasaki et al., [67] cinnamaldehyde was investigated
for its ability to enhance adrenaline secretion as an indicator of energy
metabolism and thermogenesis in rats. A number of results were col-
lected as part of this investigation. For example, the intravenous ad-
ministration of 10mg/kg cinnamaldehyde to male Sprague-Dawley rats
(7–8weeks of age) increased the adrenaline secretion from the adrenal
gland in a concentration-dependent manner. After approximately
2min, the adrenaline secretion increased to approximately 110 ng/kg/
min relative to the vehicle control of approximately 20 ng/kg/min at
the same time point. Additionally, cinnamaldehyde at the same dose
was observed to enhance the total adrenaline secretion for 20min after
sample injection, increasing this value to approximately 1250 ng/kg
relative to the vehicle control of 250 ng/kg. These results are sig-
nificant, as the authors suggest that adrenaline secretion via the intake
of a TRPA1 agonist, such as cinnamaldehyde, might be an explanation
for diet-induced thermogenesis caused by such spices as cinnamon [67].
Michlig et al. [68] studied the effects of the ingestion of TRP
channel agonists, including cinnamaldehyde, on metabolism and re-
lated processes through the stimulation of the sympathetic nervous
system. This study was conducted on men, deemed to be in good health,
between 20 and 50 years old with a weight greater than 60 kg. The
group hypothesized that the stimulation of such TRP pathways as
TRPA1 could increase thermogenesis, promoting energy expenditure
and consequently exhibit an anti-obesity effect. A number of results
were obtained to investigate this hypothesis. One such result showed
that a single administration of 350 ppm cinnamaldehyde increased
energy expenditure by approximately 3.6 kcal over the course of the 90-
min experiment, as compared to the placebo. Additionally, it was
shown that cinnamaldehyde and capsaicin, which has been widely
studied for its thermogenic and metabolic effects, exhibited similar
peripheral thermoregulation once ingested. Importantly, the dose of
cinnamaldehyde was not judged to be sensorially ‘too intense’ by par-
ticipants, as has been reported with respect to capsaicin. This led the
authors to suggest that cinnamaldehyde may be more potent than
capsaicin in terms of improving energy expenditure via thermogenic
effects [68]. While thermogenesis induced by spices is a well-studied
area of research, Pandit and Anilakumar [69] note that, prior to 2017
when they conducted their study, there had been no investigation as to
whether the ingestion of spices that induce thermogenic mechanisms
can improve cold endurance. They note that this could be an important
application, given that potentially it could delay or prevent hy-
pothermia. In this study, cinnamon extracts in a dose of 250mg/kg for a
7-day period was administered to six male Albino Wistar rats. A number
of results were obtained as part of this study. One such result was the
recording of core body temperature before and after treatment, and
after exposure of the rats to 4 ± 1 °C. After treatment with cinnamon
extracts, a statistically significant improvement was observed relative
to the control. With respect to the control, core body temperature fell
by 10 °C after treatment whereas after cinnamon extract ingestion, core
body temperature fell by 5 °C. On the basis of evidence in the literature,
the group hypothesized that the observed effects may be due to cin-
namaldehyde content in the cinnamon extract and as a result ad-
ministered cinnamaldehyde alone to investigate this. However,
A.A. Doyle and J.C. Stephens Fitoterapia 139 (2019) 104405
4
endurance was not observed to improve when it was administered in a
dose approximately equivalent to the cinnamaldehyde content of the
cinnamon extract sample. For example, the core body temperature fell
by approximately 7 °C after treatment with cinnamaldehyde. Despite
confirming the presence of cinnamaldehyde in the cinnamon extract by
HPLC and MS analysis, the lack of improved endurance following ad-
ministration of cinnamaldehyde indicated to the authors that the ob-
served thermogenesis of cinnamon extract may be as a result of a sy-
nergistic action of the various components it contains in addition to
cinnamaldehyde [69].
3. Molecular mechanism: cinnamaldehyde as an electrophile
Cinnamaldehyde has two electrophilic reactive sites, the β‑carbon
on the conjugated double bond and the carbon of the aldehyde carbonyl
group [17]. A number of previous studies have related the bioactivity of
cinnamaldehyde and its derivative to its potential Michael acceptor
ability, i.e. nucleophilic attack at the β‑carbon. For example, Cabello
et al. [38] related the Michael acceptor ability of trans-cinnamaldehyde
and a range of its derivatives to their ability to impair melanoma cell
proliferation, viability, invasiveness, and NF-κB transcriptional activity.
They observed that trans-cinnamaldehyde, but not structurally similar
compounds devoid of Michael acceptor ability such as cinnamyl alcohol
(Fig. 1, structure 17), possessed this ability [38]. A related example can
be found in the findings of Motohashi et al. [39] who conducted a
structure–activity relationship study using antimutagenic benzalace-
tone (Fig. 1, structure 12), as well as a number of cinnamaldehydes and
cinnamic acids. This group similarly found that the presence of the
unsaturated bonded‑carbonyl system is necessary for biological activity,
namely the inhibition of mutagenesis activity [39].
G. Brackman et al. [70] conducted a structure-activity relationship
of cinnamaldehyde analogues as AI (autoinducer)-2 based quorum
sensing inhibitors in Vibrio spp. It was suggested that those analogues
containing an α,β-unsaturated acyl group with potential to act as Mi-
chael acceptors (for example 2-nitrocinnamaldehyde 18 3,4-di-
chlorocinnamaldehyde 19 and cinnamaldehyde 1, were found to pos-
sess greater activity with respect to the inhibition of bioluminescence of
V. harveyi BB170. However, analogues that did not possess an α,β-un-
saturated acyl group, such as 3-phenylpropionaldehyde 20, did not
result in a significant inhibition of the bioluminescence signal and is
discussed in more detail in section 4.3.2. The group proposed that these
effects may be as a result of a Michael-addition reaction in the me-
chanism of action, allowing trans-cinnamaldehyde and its analogues to
act as LuxR-ligands. This could yield a modified protein that likely re-
sulted in the reduced ability to bind to DNA. The reduced DNA binding
was observed experimentally and measured in terms of Kd values, see
section 4.3.2.
More recent studies have however indicated, perhaps surprisingly,
that it is the carbonyl carbon that is more significant in terms of re-
activity than the β‑carbon. For example, Sadofsky et al. [71] in-
vestigated the mechanism leading to the activation of TRPA1 (transient
receptor potential ankyrin 1), a cation channel that plays an important
role in the sensation of pain, inflammation, and coughs. Specifically,
this group investigated the mechanism by which TRPA1 of cysteine
residues is activated. This was done through the examination of a series
of α,β-unsaturated carbonyl compounds that are capable of undergoing
either direct and/or conjugate addition processes. The data presented
indicates that TRPA1 is activated by direct addition of the thiol group of
cysteines to the agonist carbonyl carbon. This was assessed by analysing
a range of compounds, for example, cinnamic acid, acrylic acid, and
acrylamide, all of which were chosen as they contain both a carbonyl
carbon and an unsaturated β‑carbon but are weakly electrophilic at the
carbonyl carbon. These compounds were observed to cause little or no
TRPA1 activation in concentrations up to 300 μM. In contrast those
compounds such as acrolein and cinnamaldehyde, which can react via
either conjugate addition at the β‑carbon or reversible direct addition at
the carbonyl carbon, caused TRPA1 activation in a concentration de-
pendent manner. With respect to these reactive aldehydes, the authors
indicate that it is the reversible direct addition that is responsible for
the channel activation, which would explain why TRPA1 agonists such
as cinnamaldehyde acted in a manner compatible with reversible,
competitive agonism. Similarly, both hydrocinnamic acid NHS ester
and propionic acid NHS ester, which are only capable of direct addition,
activated TRPA1 expressed in HEK293 cells [71].
Autelitano et al. [72] investigated the reaction of cinnamaldehyde
and cinnam(o)yl derivatives with thiols. Here dodecanethiol was em-
ployed as a model of simple thiols, with cysteamine utilized as a model
of reactive protein thiols in an NMR assay as developed by Avonto et al.
[73]. This study was carried out to probe the selective reactivity of
cinnamaldehyde at both the carbonyl carbon and the β‑carbon. Other
compounds were also investigated in this study, for example cinnamyl
ketones and oximes, with most exhibiting no reactivity. Cinnamalde-
hyde, when reacted with cysteamine, afforded a mixture of a thiazoline
derivative and compounds of multiple addition at both the carbonyl
and β‑carbon. The reaction with dodecanethiol gave a bis-dithioacetal
via direct addition, but no reaction occurred between dodecanethiol
and the saturated dihydrocinnamaldehyde (Fig. 1, structure 20). A
possible explanation was given in that for cinnamaldehyde (vs dihy-
drocinnamaldehyde) conjugation to a phenyl reduces the hardness of
the carbonyl to the point of making it possible for a weak and soft
nucleophile like sulfur to attack it without any previous catalysis. These
surprising results, suggest that cinnamaldehyde can trap simple thiols
via direct addition, and can also trap cysteamine type thiols but only
after imine formation with the amino motif [72].
4. Antibacterial activity of cinnamaldehyde and its derivatives
trans-Cinnamaldehyde has known antibacterial properties that have
been established across an array of Gram-positive and -negative bac-
teria, including E. coli [6,10,12,23,74] Bacillus subtilis (B. subtilis)
[10,12,74], Staphylococcus spp. [12,17,23,74], Listeria spp. and Salmo-
nella spp. [6,10,12,17,74], Lactobacillus sakei [74], Campylobacter jejuni
[6,75], Vibrio spp. [3,10,12], Pseudomonas spp. [3,10,12,23], Porphyr-
omonas gingivalis [12], Streptococcus pyogenes [3], and Cronobacter sa-
kazakii [12,17].
Some recent research has utilized trans-cinnamaldehyde as a hit
compound, from which a range of derivatives have been synthesized
and tested for their antibacterial activity. The following section high-
lights publications in which trans-cinnamaldehyde and derivatives have
been investigated for their general antibacterial activity without re-
porting on a mechanism of action. One such case is that of Wei et al.
[58], who developed nine Schiff base cinnamaldehyde compounds and
tested them, along with cinnamaldehyde, against B. subtilis and E. coli.
The antimicrobial activity of the Schiff base adducts were very near or
higher than cinnamaldehyde. At the same molar concentration po-
tassium (E)-N-[((E)-3-phenyl-1-ethenyl)methylene]glycinate (Fig. 2,
structure 21), formed by the reaction of potassium glycinate with cin-
namaldehyde, was found to be more active than cinnamaldehyde. The
inhibition zone diameters of 21, at a concentration of 600mg/L
(2.64 mmol/L), for E. coli and B. subtilis were 11.8 mm and 12.6mm
respectively. The inhibition zone diameters of cinnamaldehyde, for the
same bacteria at a concentration of 400mg/L (3.0 mmol/L), were
10.3 mm and 11.0 mm respectively. It is also noteworthy that 21 ex-
hibited practically no associated toxicity according to the criteria of
acute toxic classifications, where it was determined that the oral acute
toxicity was more than 2500mg/kg body weight in mice [58]. Fol-
lowing on from this work, Wang et al. [76] synthesized twenty four
Schiff base cinnamaldehyde analogues using cinnamaldehyde, 4-
chlorocinnamaldehyde, and 4-methoxycinnamaldehyde as the cinna-
maldehyde component. The three cinnamaldehydes were combined
with one of eight amino acids to generate the corresponding Schiff base.
Results indicate that all compounds inhibited the growth of the two
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bacteria Staphylococcus aureus (S. aureus) and E. coli. 22 and 23 (Fig. 2)
exhibited the best antibacterial activity. 23 had the highest associated
inhibition zone diameter of 31.3 mm against E. coli, compared to that of
cinnamon oil of 29.5 mm and that of the common antibiotic cipro-
floxacin of 24.3 mm. 22 had the highest associated inhibition zone
diameter of 33.7 mm against S. aureus, compared to that of cinnamon
oil of 10.5 mm and that of ciprofloxacin of 21.0mm. These results were
all generated with test concentrations of 0.25mol/L. Two mold fungi
were also examined in this study and it was found that they were more
sensitive to the cinnamaldehyde derivatives than the two test bacteria
[76].
In 2016, Liu et al. [77] synthesized Schiff base cinnamaldehyde
metal complexes using γ-aminobutyric acid (GA) and cinnamaldehyde,
as well as copper (Cu2+) and zinc (Zn2+). The Schiff base-metal com-
plexes were evaluated for their inhibitory effect against S. aureus and E.
coli. The cinnamaldehyde-GA Schiff base was shown to possess better
antibacterial activity against S. aureus than E. coli, as assessed by MBC
(minimal bactericidal concentration) values. An MBC of 46 μg/mL
against S. aureus was reported and compared to an MBC of 375 μg/mL
against E. coli. For S. aureus, both metal complexes of cinnamaldehyde-
GA were shown to enhance the antimicrobial activity compared to the
cinnamaldehyde-GA Schiff base alone, where the MBC of the cinna-
maldehyde-GA-Cu2+ complex was found to be 11 μg/mL and that of the
cinnamaldehyde-GA-Zn2+ complex was found to be 23 μg/mL. How-
ever, only the cinnamaldehyde-GA-Cu2+ complex improved the activity
of the original Schiff base with respect to E. coli, whose MBC value was
determined as 187 μg/mL. The cinnamaldehyde-GA-Zn2+ complex
showed the same activity as original Schiff base, with a MBC value of
375 μg/mL. Thus, while this study showed that the cinnamaldehyde-GA
Schiff base possessed good antibacterial effects, its activity can be en-
hanced by complexing with Cu2+ and also Zn2+ in the case of S. aureus
[77].
Shen et al. [78] investigated the ability of cinnamaldehyde and its
derivatives to eradicate persisters in E. coli. Persisters lead to recurring
infections and relapse after treatment and are widely occurring
throughout bacteria as well as fungi and parasites. α-Bromocinna-
maldehyde (Fig. 2, structure 24) was shown to exhibit the best activity
of those compounds evaluated, having an associated killing rate of
100% in concentrations up to 400 μg/mL, compared with cinna-
maldehyde having a similar killing rate of 99.8% across the same
concentrations. Less than 1% of cells survived after administration of α-
bromocinnamaldehyde at a concentration of 100 μg/mL, and at a
Fig. 2. Cinnamaldehyde derivatives shown to pos-
sess general antibacterial activity. [58,76,78].
Fig. 3. Graphical depiction of antibacterial mechanisms of action exhibited by cinnamaldehydes.
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concentration of 400 μg/mL α-bromocinnamaldehyde was able to era-
dicate all E. coli cells in the exponential phase as well as cells in the
stationary phase. Cells in the stationary phase are often resistant to
traditional antibiotic treatment. Interestingly, α-methylcinnamalde-
hyde (Fig. 2, structure 25) was shown not to display any bactericidal
activity at any concentration examined, while phenylpropyl aldehyde
(Fig. 1, structure 20), without an α,β-unsaturated bond, exerted bac-
tericidal activity with an associated killing rate of 92.1%. The group
also found that α-bromocinnamaldehyde displayed a mechanism of
action that is different from some common antibiotics. For example,
results from this study indicate that the mechanism of action for α-
bromocinnamaldehyde is independent of Reactive Oxygen Species
(ROS) [78].
While there are many examples in the literature of studies exploring
the antibacterial activity of trans-cinnamaldehyde, there are fewer
where the antibacterial activity of cinnamaldehyde derivatives along
with their mechanism of action have been studied. In the following
sections of this review, we would like to highlight publications that
offer significant insight into the mechanism of action of trans-cinna-
maldehydes and have grouped the selected publications into the dif-
ferent proposed mechanisms of action (Fig. 3). We do recommend that
the reader consults the referenced articles in order to fully explore each
citation.
4.1. FtsZ inhibition by cinnamaldehydes
Filamentous temperature-sensitive protein Z (FtsZ) is a key cyto-
plasmic protein in the cell division process [79–83]. FtsZ was dis-
covered in the 1970s [80] and is conserved in virtually all bacterial
species [79–82]. For example, FtsZ is present in the cells walls of such
bacteria as E. coli and Bacillus subtilis [81], as well as in archaea [79,82],
and chloroplasts [79]. In 1991, it was found that FtsZ assembled into a
ring structure, termed a Z-ring, at the center of the cell [84] and that
this Z-ring dynamic structure is essential in facilitating cytokinesis and
recruiting other cell division proteins that bind to the Z-ring sequen-
tially. Subsequently, the Z ring contracts leading to the closure of the
septum, which coincides with the formation of two daughter cells
[79,80,83,84]. FtsZ is an important GTPase and is considered to be a
homolog of eukaryotic tubulin [80,82,83]. However, it does possess
certain structural features that are different than tubulin; notably
greater than 80% of the FtsZ primary sequence varies to that of tubulin
[84]. Additionally, FtsZ subunits are indistinguishable, whereas eu-
karyotic microtubules are made up of two distinct tubulin subunit types
(α and β) [84]. The presence of such differences between FtsZ and
tubulin is important, and supports the hypothesis that antibacterial
agents could potentially be developed that selectively target FtsZ over
tubulin in vivo. Consequentially, this would lower the risk of accom-
panying adverse effects upon administration [84]. Such selective tar-
geting, along with its fundamental role in the bacterial cell division
process and presence in such a variety of bacteria, makes FtsZ an at-
tractive target for researchers involved in the development of novel
antibacterial agents [79,81,82]. trans-Cinnamaldehyde, as well as some
of its derivatives, have been shown to inhibit the cell division process
by binding to FtsZ.
4.1.1. FtsZ inhibition by trans-cinnamaldehyde
Domadia et al. [85] made valuable contributions to the under-
standing of how trans-cinnamaldehyde inhibits FtsZ with a number of
important observations. The group noted that even at doses exceeding
its MIC and MBC values, where the MIC was found to be 1 g/L and
0.5 g/L respectively for E. coli and B. subtilis and the MBC was 1 g/L for
both strains, that trans-cinnamaldehyde did not possess any hemolytic
activity toward human eukaryotic cells. The group also analyzed the
effect of trans-cinnamaldehyde on FtsZ polymerization and GTPase
activity in E. coli and saw that both were strongly inhibited. Here trans-
cinnamaldehyde exhibited half-maximal inhibitory concentration (IC50)
values of 6.86 ± 2.2 μM and 5.81 ± 2.2 μM respectively. A nearly
linear relationship was observed between antibacterial activity (in-
dicated by the MIC for E. coli) and the FtsZ inhibition IC50 for E. coli,
thus suggesting that FtsZ could be a selective target for trans-cinna-
maldehyde. This was supported by the results obtained using iso-
thermal titration calorimetry in the same study, which revealed that the
binding of trans-cinnamaldehyde to FtsZ is driven by favourable en-
thalpic interaction, where ΔH was found to be negative and a negative
binding free energy was observed. An exothermic and thermo-
dynamically driven FtsZ-cinnamaldehyde interaction was also shown
by this method and an association constant of 1.0 ± 0.2M−1 was
found [85]. This group also showed that trans-cinnamaldehyde in-
hibited the bundling of FtsZ protofilaments in a dose-dependent manner
in vitro. In the presence of 100 μM trans-cinnamaldehyde, polymeriza-
tion was almost completely inhibited. In addition, confocal imaging
showed that 100 μM trans-cinnamaldehyde disturbs Z-ring morphology
in vivo, causing a reduction of Z-rings from 85.7% in the untreated
control to 58% after treatment, as well as a reduction in the frequency
of Z-rings per unit cell length of E. coli from 5.00 in the control to 2.88
after exposure [85].
Additionally, Domadia et al. [85] conducted analysis of the binding
site of cinnamaldehyde in FtsZ using saturation transfer difference
(STD)-NMR spectroscopy and in silico docking techniques. The study
indicated that cinnamaldehyde binds to the T7 loop in the C-terminal
region of a FtsZ monomer. This binding induces a conformation change
that inhibits GTP-dependent FtsZ polymerization by blocking optimal
contact with the GTP-binding T1-T6 loop in the neighbouring
monomer. It was also shown using STD-NMR spectroscopy that it is the
H2 and H3 protons of the conjugated alkene of cinnamaldehyde that are
in close contact with FtsZ protons in its binding pocket. At that time,
cinnamaldehyde was the only molecule known to target the T7 loop in
FtsZ [85], although since then other molecules have been implicated as
targeting the T7 loop directly or as binding in close proximity to the T7
loop. Such compounds include coumarins, such as scopoletin
[80,81,86], 2,4-disubstituted benzimidazoles, such as BT-Benzo-29
[81], benzamide derivatives, such as PC190723 [86], and cathelin-re-
lated antimicrobial peptide (CRAMP) [80,81,86] (Fig. 4, structure
26–28). Domadia et al. [85] note that cinnamaldehyde may represent
both a hit compound for the subsequent design of more stable and more
potent FtsZ inhibitors, as well as a vital tool for understanding the
regulatory role of FtsZ in cell division [85]. To the best of our knowl-
edge, the work of Domadia et al. is the only experimental report de-
scribing the FtsZ inhibitory activity of cinnamaldehyde. Nazzaro et al.
[10] reported that cinnamaldehyde exhibited inhibitory activity on cell
separation of Bacillus cereus [10], referencing the work of Kwon et al.
[13], but did not include results indicating the inhibition of FtsZ by
cinnamaldehyde. As such, while the reported inhibition of cell separa-
tion may be as a result of FtsZ inhibition, it was not discussed as part of
their study. The seminal work of Domadia et al. [85] remains an im-
portant contribution to this field.
4.1.2. FtsZ inhibition by cinnamaldehyde derivatives
In 2015, Li et al. [87] designed and synthesized a novel library of
trans-cinnamaldehyde derivatives and tested them for their in vitro
antibacterial activity against nine pathogen strains, including Gram-
positive and Gram-negative bacteria. The trans-cinnamaldehydes stu-
died included (E)-3-(4-fluorophenyl)-1-(2-methyl-1H-benzo[d]imi-
dazol-1-yl)prop-2-en-1-one (Fig. 4, structure 29), (E)-3-(4-chlor-
ophenyl)-1-(2-methyl-1H-benzo[d]imidazol-1-yl)prop-2-en-1-one
(Fig. 4, structure 30), and (E)-3-(2,4-dichlorophenyl)-1-(2-methyl-1H-
benzo[d]imidazol-1-yl)prop-2-en-1-one (Fig. 4, structure 31). These
three examples displayed good antimicrobial activity and were eval-
uated by carrying out light scattering and GTPase assays in order to
further validate the FtsZ targeted mechanism. In the light scattering
assay, all the tested compounds displayed an obvious inhibition on FtsZ
polymerization in a dose-dependent manner. The intensity of light
A.A. Doyle and J.C. Stephens Fitoterapia 139 (2019) 104405
7
scattering for the E. coli ATCC 25922 untreated control was measured as
3000 by the end of the experiment at 2000 s, which was reduced to
1000 at the 2000 s timepoint after administration of 120 μg/mL 29 and
to 1500 after administration of 120 μg/mL of 30 and 31 (at the same
timepoint). 31 was the most active derivative tested and at a lowest
concentration of 30mg/mL reduced the intensity of light scattering
intensity of E. coli ATCC 25922 to approximately 1750.
Li et al. [87] also described, in the same publication, the use of a
GTPase assay, where the library of cinnamaldehyde derivatives tested
tested exhibited a dose-dependent effect on the GTPase activity of FtsZ.
Again compound 10 exhibited the best activity of those derivatives
examined, showing 50% inhibition of the GTPase activity of E. coli
ATCC 25922 at the lowest concentration studied of 30mg/mL. The
inhibition of GTPase activity resulted a loss of stability for the FtsZ
polymer, leading to abnormal bacterial cell division and then to cell
death. The results suggested that the three compounds exhibiting the
best antimicrobial activity are worth considering for further investiga-
tion as potent FtsZ-targeted antibacterial agents. Additionally, these
compounds exhibited promising antibacterial activity against S. aureus
ATCC25923, where for example, 31 was found to elicit a minimum
inhibitory concentration of 4 μg/mL [87].
4.2. Biofilm inhibition by cinnamaldehydes
Biofilms are clusters of surface-associated microorganisms that are
surrounded by a self-produced extracellular polymeric matrix [88]. A
large body of research has been carried out in recent years examining
the inhibition of biofilm formation as a potential mode of action for
antibiotic agents. In the United States alone, an estimated 80% of
hospital-acquired infections are caused by bacterial biofilms, which
lead to 60,000–90,000 deaths annually and amounts to an economic
burden of $17–$29 billion each year [89]. In addition, according to the
National Institutes of Health, up to 80% of bacterial infections that
occur in humans involve biofilm-associated microorganisms [90].
Those bacteria associated with biofilm production are shown to be
more resistant to both host defenses and antibiotic treatments, thus
resulting in persistent and potentially less curable infections [90]. As
such, microbial biofilms present a major challenge in both health and
industrial settings [12], with an immediate need for novel strategies to
treat these biofilm-associated infections [88]. The ability to target the
biofilms associated with bacteria could provide a more specific treat-
ment than traditional antibiotics, for example if biological effects spe-
cifically target the biofilm microenvironment. This would result in the
degradation of the matrix, resulting in the eradication of associated
pathogens with precision and therefore minimal cytotoxicity to sur-
rounding tissues [91]. trans-Cinnamaldehyde itself has been the subject
of many studies in this area and investigations of its antibiofilm prop-
erties have been conducted across a range of bacteria. There have been
fewer biofilm inhibition studies involving derivatives of trans-cinna-
maldehyde.
4.2.1. Antibiofilm activity of trans-cinnamaldehyde against E. coli
The inhibitory action of trans-cinnamaldehyde on biofilm formation
has been reported across a number of different strains of E. coli, in-
cluding uropathogenic E. coli [92,93], E. coli ATCC 33456 [94], and
enterohemorrhagic E. coli O157: H7 (EHEC) [95]. In some cases, trans-
cinnamaldehyde has even been shown to eradicate already established
biofilms on different surfaces such as polystyrene and latex [93], giving
rise to its potential application in clinical settings such as on catheters
[92]. It has been shown that by increasing the concentration of cin-
namaldehyde, the specific biofilm formation observed was reduced (for
example, the specific biofilm formation was reduced by approximately
46% relative to that of the control after administration of 2.01mM
cinnamaldehyde), as well as the specific cell adhesion (which was re-
duced by approximately 50% relative to that of the control after ad-
ministration of 2.12mM cinnamaldehyde) [94]. Transcriptional ana-
lysis showed that cinnamon bark oil, of which cinnamaldehyde is a
major component, down-regulated curli genes and Shiga-like toxin gene
stx2 in EHEC at a concentration of 0.01% v/v [95]. It has also been
shown to restrict the swimming motility of some E. coli strains by up to
60% when cells were exposed to cinnamaldehyde at a concentration of
2.17mM [94], and importantly did not exhibit any toxic effect on
bladder epithelial cells at 1%, 1.25% or 1.5% concentrations [93]. It
has been suggested that the aldehyde functional group in trans-cinna-
maldehyde contributes to its antibiofilm activity [92]. This was de-
duced by Kot et al. [92] on the basis that trans-cinnamaldehyde was the
only compound of the three plant-derived molecules evaluated capable
of completely eliminating the biofilm of uropathogenic E. coli Trans-
Cinnamaldehyde was found to be the only compound that possessed an
aldehyde functional group, the other two chemicals were carboxylic
acids [92]. Across these studies it can be said that cinnamaldehyde may
potentially be a safe, effective antibiofilm agent that could be used to
prevent and inactivate E. coli-biofilm related infections. Additionally,
the fabrication of materials such as PLGA (poly(lactic-co-glycolic acid))
coated with cinnamaldehyde or cinnamon bark oil was also shown to be
effective at inhibiting EHEC biofilm formation at a concentration of
0.25%, as visualized by confocal laser microscopy [95]. This shows the
potential of not just cinnamaldehyde itself in this area but also other
formulations of which this compound is a main constituent.
4.2.2. Antibiofilm activity of trans-cinnamaldehyde against S. aureus
The cinnamaldehyde inhibition of several clinical strains of
Fig. 4. The chemical structures of those compounds known to target the T7 loop of FtsZ (structures 26–28) [80,81,86], and those cinnamaldehyde derivatives
evaluated for their FtsZ inhibitory ability (structures 29–31) [87].
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methicillin-resistant Staphylococcus aureus (MRSA) biofilms [88,96],
SC-01 (an oxacillin- and methicillin-resistant clinical isolate of S.
aureus) and its biofilms [97], as well as the biofilms of various isolates
of S. aureus recovered from cases of subclinical bovine mastitis [98], has
been reported. The work presented by Kavaunagh and Ribbeck [97] is
perhaps particularly noteworthy as it was the first study to examine the
effect of essential oils on the SC-01 strain. Here they showed that cassia
oil, of which cinnamaldehyde is a major component, inhibited biofilm
formation of this strain, with a minimal biofilm eradication con-
centration determined as approximately 0.5% v/v [84]. This level of
activity makes it more active against the SC-01 strain than the com-
monly used antibiotic treatments oxacillin- and methicillin [97]. trans-
Cinnamaldehyde has not only been reported to inhibit the biofilm mass
of S. aureus by up to 82.4% after a 48 h incubation period, depending on
the strain, it can also reduce the metabolic activity of associated bio-
films by 76.7–85.5% and 79.3–86% after 24 h and 48 h of treatment
(using 0.1% v/v trans-cinnamaldehyde in all cases) [96]. Additionally,
it was shown using real-time PCR that there was a notable decrease in
sarA expression, sarA being a positive regulator of biofilm-associated
protein, after exposure to trans-cinnamaldehyde. In some cases this was
substantial, such as that observed for the JB-03 clinical strain where a
140-fold reduction in the expression of sarA was observed after treat-
ment with 0.0625% (v/v) cinnamaldehyde [88]. These results collec-
tively indicate the potential of cinnamaldehyde in the treatment of
MRSA biofilm-related infections. Budri et al. [98] suggested that upon
further development, an attractive application for cinnamaldehyde
could materialize where it is employed as an alternative to sanitizing
spray for use in the food processing industry. The Budri group reported
that biofilms on two different surfaces, polystyrene and stainless steel,
were reduced by 69.6% and 44.9% respectively after treatment with a
concentration of 0.106mg/mL cinnamaldehyde [98].
4.2.3. Antibiofilm activity of trans-cinnamaldehyde against Pseudomonas
spp.
trans-Cinnamaldehyde has also been investigated with respect to its
effect on biofilms associated with Pseudomonas spp. For example,
Kavanaugh and Ribbeck [97] showed that cinnamaldehyde was effec-
tive in eradicating Pseudomonas aeruginosa (PAO1) biofilms, exhibiting a
minimal biofilm eradication concentration of 0.2% v/v. This group also
reported that cinnamaldehyde was as effective as cassia oil which
generated the same minimal biofilm eradication concentration [97].
This is in agreement with the work of Kim et al. [95], who made the
same observation regarding the antibiofilm activity against PAO1 of
cinnamon bark oil, whose main constituent is also cinnamaldehyde.
Here, cinnamon bark oil was shown to inhibit PAO1 biofilms by 96% at
a concentration of 0.05% v/v, with cinnamaldehyde showing similar
activity at the same concentration. Additionally, this group found that
the swarming motility of P. aeruginosa was almost abolished by the
administration of 0.005% v/v cinnamaldehyde and 0.005% v/v cin-
namon bark oil, as visualized using motility agar and compared to an
untreated control [95]. The hemolytic activity of P. aeruginosa was also
reduced by exposure to both cinnamon bark oil and cinnamaldehyde.
The effect was more pronounced in the case of cinnamon bark oil,
which at 0.02% v/v reduced hemolytic activity by more than 50%,
while cinnamaldehyde at the same concentration reduced this by ap-
proximately 40%. The production of PQS (Pseudomonas quinolone
signal, a quorum sensing molecule) was also inhibited by approximately
60% after treatment with cinnamon bark oil at 0.02% v/v and by ap-
proximately 30% after treatment with cinnamaldehyde at the same
concentration [95].
Niu et al. [94] found that the specific biofilm formation by PAO1
decreased at cinnamaldehyde concentrations lower than 2mM, but
increased at cinnamaldehyde concentrations greater than 2mM. This
behavior was reasoned by the authors in terms of the activation of a
stress-induced response leading to increased crystal violet (CV)
staining, which is a colorimetric method that is widely used to measure
biofilm formation, thus leading to the observed increase in specific
biofilm formation. This group additionally found that P. putida KT2440
biofilms were reduced on increasing cinnamaldehyde concentration
(for example, its specific biofilm formation was reduced by more than
80% at the highest concentration administered of 3mM cinnamalde-
hyde, relative to the control). However, the specific biofilm formation
of P. fluorescens pSMC21 was observed not to be significantly inhibited
at any concentration of cinnamaldehyde administered [94]. Li et al.
[99] observed a clear inhibitory activity of cinnamaldehyde against P.
fluorescens ATCC 13525 biofilms, with a decrease of approximately
35.74% being recorded after treatment with 0.025 μL/mL cinna-
maldehyde. Further decreases were observed at higher concentrations
of this compound, where the maximum biofilm inhibition rate recorded
was 54.48% with the administration of 0.1 μL/mL cinnamaldehyde
[99].
4.2.4. Antibiofilm activity of trans-cinnamaldehyde against Crotobacter
sakazakii
The antibiofilm activity of trans-cinnamaldehyde has been in-
vestigated across a range of other bacteria, including Crotobacter sa-
kazakii [100]. Here, Amalaradjou and Venkitanarayanan found that the
inhibitory effect of trans-cinnamaldehyde on C. sakazakii biofilm for-
mation significantly increased in a concentration dependent manner.
For example, at 24 °C 750 μM trans-cinnamaldehyde reduced biofilm
associated C. sakazakii counts on microtiter plates to approximately
2.40 log CFU after a 96-h incubation period. This was in comparison
with samples treated with 560 μM trans-cinnamaldehyde, which con-
tained more than 4.0 log CFU by the end of the same incubation period.
This inhibitory effect was also demonstrated on other surfaces such as
enteral feeding tubes and stainless steel. This group also showed that
trans-cinnamaldehyde was capable of inactivating fully formed C. sa-
kazakii biofilms on many abiotic surfaces [100]. For example, a study
using feeding tubes showed a reduction in biofilm-associated popula-
tion from approximately 5 log CFU/piece to less than 1.5 log CFU/piece
on treatment with 38mM trans-cinnamaldehyde. They also found, using
reverse transcription quantitative PCR, that trans-cinnamaldehyde was
able to significantly downregulate the expression of genes that were
linked to biofilm formation, especially bcsA and LuxR, which were
downregulated 71.43 fold and 20.83 fold respectively after exposure to
750 μM trans-cinnamaldehyde [100]. Albano et al. [101] found that
Staphylococcus epidermis biofilms on polystyrene microtiter plates were
reduced by 74%, 84%, and 89% after treatment with 70%, 80%, and
90% of the minimum inhibitory concentration (300 μg/mL for all ATCC
strains) of trans-cinnamaldehyde respectively. Smaller reductions were
observed with respect to the biofilms of the clinical isolate at 73%,
80%, and 84% after treatment with 70%, 80%, and 90% of the
minimum inhibitory concentration (400–500 μg/mL for this strain)
[101].
4.2.5. Antibiofilm activity of trans-cinnamaldehyde & its derivatives against
Streptococcus pyogenes
Additionally, the ability of cinnamaldehyde and synthesized deri-
vatives to inhibit the biofilm formation of a clinical isolate of
Streptococcus pyogenes (SP5) was examined by Shafreen et al. [102].
Biofilm inhibitory concentration (BIC) values obtained were of the
following order; 2-nitrocinnamaldehyde had the lowest BIC of 200 μM/
mL (Fig. 1, structure 18) followed by 4-nitrocinnamaldehyde (BIC:
250 μM/mL) (Fig. 5, structures 29), and then cinnamaldehyde (Fig. 1,
structure 1) and 4-(dimethylamino)cinnamaldehyde (both, BIC:
300 μM/mL) (Fig. 5, structure 30). This group also found, through
analysis using confocal laser scanning microscopy (CLSM), that these
compounds all led to decreases in biomass, average thickness, and
colony size at their respective BIC values. For example, 2-ni-
trocinnamaldehyde, at its BIC, reduced the biomass from 35.4 μm3/μm2
in the untreated SP5 biofilm to 2.1 μm3/μm2 and reduced the average
colony size at the substratum from 180,706.6 μm2 in the untreated SP5
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biofilm to 409.0 μm2. Cinnamaldehyde reduced the same control bio-
mass of 35.4 μm3/μm2 to 3.9 μm3/μm2 and reduced the average colony
size at the substratum from 180,706.6 μm2 to 13,331.09 μm2 [102].
This showed the improved activity of 2-nitrocinnamaldehyde relative to
cinnamaldehyde at their respective BIC values.
4.2.6. Antibiofilm activity of trans-cinnamaldehyde against Salmonella
Typhimurium
Silva et al. [103] investigated the effect of cinnamaldehyde on
biofilms of Salmonella Typhimurium ATCC 14028. Here the group found
that the biomass of these biofilms was significantly reduced by 21%
after exposure to cinnamaldehyde at 312 μg/mL and by 40% after ex-
posure to cinnamaldehyde at 624 μg/mL. The associated metabolic
activity of preformed biofilms was also reduced, where treatment with
cinnamaldehyde at 312 μg/mL reduced activity by 39% and treatment
with 624 μg/mL reduced activity by 65%. It was also shown that cin-
namaldehyde reduced the number of attached cells on polypropylene
from 8.03 log10 CFU/cm2 to 6.90 and 5.70 log10 CFU/cm2 after 1 h
exposure to 312 μg/mL and 624 μg/mL cinnamaldehyde respectively.
The number of attached cells was assessed by colony count and visua-
lized additionally by scanning electron microscopy (SEM). The efficacy
of the antibiofilm properties of cinnamaldehyde was observed to in-
crease as its concentration was increased. This was demonstrated via
the change in biofilm biomass upon exposure to 312 μg/mL and 624 μg/
mL cinnamaldehyde. Proteomic analysis additionally found that per-
oxiredoxin, conjugal transfer nickase/helicase TraI, and elongation
factor G were all upregulated in untreated-biofilm cells compared to
planktonic cells. Specifically these proteins were upregulated by 7.6-
fold, 7.6-fold and 7.0-fold, respectively and their expression decreased
as a function of cinnamaldehyde concentration, which was adminis-
tered at a concentration of 624 μg/mL. Thus, these differentially ex-
pressed proteins have the potential to be possible targets in new ther-
apeutic strategies for the treatment and prevention of S. Typhimurium
biofilm formation [103].
4.2.7. Effect of trans-cinnamaldehyde on the morphology of bacterial
biofilms
Aside from the preventative and inhibitory action exhibited by
cinnamaldehyde on a range of bacterial biofilms, its effects on the
morphology of biofilms have also been examined using CLSM and SEM.
Examples of such studies include that by Kim et al. [95] who, using
SEM, observed a clear reduction in the production of fimbriae at 0.01%
v/v cinnamaldehyde and cinnamon bark oil. Fimbriae are important for
EHEC biofilm formation as they aid in the maturation process and fa-
cilitate the production of dense biofilms [104]. Also, few biofilm cells
were observed to attach to nylon filters in the presence of cinna-
maldehyde, and overall the SEM results suggested biofilm inhibition
was caused by the decrease in fimbriae production [95]. Using CLSM,
Niu and Gilbert [94] observed that E. coli ATCC 33456 cells were
elongated with visible signs of induced physical stress after adminis-
tration of cinnamaldehyde at 2.17mM. Five parameters, which char-
acterize biomass, were calculated by COMSTAT to analyze biofilm
structure with and without treatment; total biomass, maximum biofilm
thickness, substratum coverage, surface-to-biovolume ratio, and
average diffusion distance. A decrease in three of these five parameters
was observed after administration of cinnamaldehyde compared to
biofilms grown on LB medium alone. For example, maximum thickness
of the biofilm was reduced from approximately 46.2 μM to approxi-
mately 18.3 μM [94]. Using CLSM images, Albano et al. [101] observed
that in the absence of trans-cinnamaldehyde, S. epidermidis 35,984 cells
formed a dense biofilm composed largely of viable cells. After treatment
with trans-cinnamaldehyde, the thickness of the biofilm was reduced
significantly with a notable alteration in morphology, the effect of
which increased with increasing trans-cinnamaldehyde concentration.
For example, in the presence of 25% minimum inhibitory concentration
(where the MIC was determined as 300 μg/mL) biofilm formation was
still present, but with a larger number of non-viable cells. This was
compared with exposure to 50 and 90% MIC, where biofilm formation
was prevented and the bacterial cell growth was reduced with few
colonies found. The structural changes observed indicated to the au-
thors that a decrease in cell density and biofilm depth had occurred
[101].
Both CLSM and SEM techniques were employed by Li et al. [99] to
assess the effect of cinnamaldehyde on P. fluorescens biofilm formation.
Using light microscopy, this group observed that without treatment P.
fluorescens formed a dense biofilm with a convex shape. There was a
visible reduction in bacterial aggregation and number of microcolonies
observed after treatment with cinnamaldehyde, the effect of which in-
creased with increasing cinnamaldehyde concentration ranging from
0.025 to 0.1 μL/mL. SEM images showed a disruption in the biofilm
architecture over time after treatment with cinnamaldehyde (con-
centration ranging from 0.025 to 0.1 μL/mL). Gaps were observed in
the biofilm at higher cinnamaldehyde concentrations (e.g. at 0.1 μL/
mL), confirming the antibiofilm activity of cinnamaldehyde [99]. Ad-
ditionally, Silva et al. [103] observed through the use of SEM, that the
S. Typhimurium ATCC 14028 biofilm structure was disrupted by treat-
ment with 624 μg/mL cinnamaldehyde. Here, SEM images showed
diffuse cells and lower adherence to polypropylene compared with
untreated biofilms. Moreover, the absence of cell aggregates was ob-
served [103].
4.3. Anti-quorum sensing activity of cinnamaldehydes
Quorum sensing (QS) controls an array of prokaryotic phenotypes
such as enzyme secretion, bioluminescence, virulence factor produc-
tion, and even biofilm production. It is a process that occurs extensively
in both Gram-positive and -negative bacteria, where autoinducer (AI)
molecules allow the bacteria to sense cell population density [105].
There is a need for new antipathogenic agents and the communication
system in bacteria presents a promising target, which could potentially
decrease the rate of resistance by avoiding the extensive use of anti-
biotics while successfully inactivating bacterial pathogenicity
[106,107]. As a result, the QS inhibitory activity of cinnamaldehyde
and its derivatives has been studied across a range of bacteria.
4.3.1. Anti-quorum sensing effect of trans-cinnamaldehyde on E. coli and
Vibrio harveyi
Niu et al. [105] explored the effect of subinhibitory concentrations
(that is, concentrations that had no inhibitory effect on the growth of
bacterial cells) of cinnamaldehyde on quorum sensing in E. coli and
Vibrio harveyi. Here, the authors found that LuxR-mediated transcrip-
tion from the PluxI promoter was inhibited by 70% after administration
of cinnamaldehyde (200 μmol/L). In addition, 100 μmol/L of cinna-
maldehyde was shown to reduce the bioluminescence of the AI-2
bioreporter V. harveyi BB170 by 62 ± 2%. This group also showed that
cinnamaldehyde (200 μmol/L) only possessed a slight inhibitory effect
of 8 ± 3% on LasR promoter activity. The authors measured LasR
promoter activity via the reduction of specific fluorescence of the PlasR-
Fig. 5. Cinnamaldehyde derivatives that are known to exhibit antibiofilm
properties [102].
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gfp bioreporter, E. coli ATCC 33456 pMHLAS [105]. In addition, Yap
et al. [107] reported on the ability of Cinnamomum verum bark essential
oil to inhibit both E. coli [pSB1075] and E. coli [pSB401] related to its
anti-QS ability. E. coli [pSB1075] and E. coli [pSB401] carry the lasR
and luxR receptor gene respectively. In this study, the bioluminescence
was recorded over a 24 h period and concentrations of 0.01% (v/v)
cinnamon bark oil reduced E. coli [pSB401] bioluminescence from
1.75×106 RLU/OD495 in the untreated cells to less than 0.575×106
RLU/OD495. At the end of the same observation period, all three con-
centrations of cinnamon bark oil investigated (0.005%, 0.0075% and
0.01% v/v), reduced the bioluminescence of E. coli [pSB1075] from
approximately 7.0×103 RLU/OD495 in the untreated control to ap-
proximately 1.0×103 RLU/OD495 [107].
4.3.2. Anti-quorum sensing effect of trans-cinnamaldehyde and its
derivatives on Vibrio harveyi
G. Brackman et al. [106] showed that cinnamaldehyde, as well as
some derivatives, affected AI-2 based QS in Vibrio harveyi BB170 by
decreasing the ability of LuxR to bind to its target promoter sequence in
a concentration-dependent manner. Cinnamaldehyde and a synthetic
derivative 2-nitrocinnamaldehyde (Fig. 1, structure 1 & 18) were
shown to be the most active compounds, which inhibited biolumines-
cence in Vibrio harveyi BB170 by 65 ± 13% and 62 ± 7%, respec-
tively at 100 μM concentration in both cases (recorded 6 h after the
addition of both compounds) [106]. More recently, in 2011, G.
Brackman et al. [70] explored this mechanism of action further by
conducting a structure-activity relationship of synthesized cinna-
maldehyde analogues as AI-2 based QS inhibitors in Vibrio spp. The
group assessed the inhibition of QS activity through exploration of the
ability to target LuxR and restrict its DNA-binding ability. It was sug-
gested that those analogues containing an α,β-unsaturated acyl group
(Fig. 1, structure 18 & 19) which can potentially act as Michael ac-
ceptors, were found to possess greater activity. For example, at 100 μM
concentration, 3,4-dichlorocinnamaldehyde (Fig. 1, structure 19), 2-
nitrocinnamaldehyde (Fig. 1, structure 18), and cinnamaldehyde in-
hibited the bioluminescence of V. harveyi BB170 by 99 ± 1%,
62 ± 7%, and 65 ± 13% respectively, relative to the untreated con-
trol. However, analogues that did not possess an α,β-unsaturated acyl
group, 3-phenylpropionaldehyde for example (Fig. 1, structure 20), did
not result in a significant inhibition of the bioluminescence signal in
concentrations of up to 100 μM. This could suggest that trans-cinna-
maldehyde and its analogues could act as LuxR-ligands via a Michael
addition mechanism. Although direct addition to the carbonyl group
could also occur, see section 3.0. Acting as a LuxR ligand, the cinna-
maldehydes could yield a modified protein that would likely result in
the reduced ability to bind to DNA. One such way the reduction of DNA-
binding ability was presented in this study was using Kd values, which
were calculated as the concentration of LuxR at the half-maximal
fractional change in fluorescence anisotropy. In the absence of trans-
cinnamaldehyde or its derivatives, a Kd of approximately 25 nM was
recorded. However, in the presence of 50 μM cinnamaldehyde, 2-ni-
trocinnamaldehyde, and 3,4-dichlorocinnamaldehyde, a Kd of ap-
proximately 40, 60, and 225 nM respectively was recorded [70].
4.3.3. Anti-quorum sensing effect of trans-cinnamaldehyde on
Pseudomonas fluorescens.
T. Li et al. [99] investigated the inhibitory ability of cinnamalde-
hyde at sublethal concentrations against QS-controlled virulence factors
in a different bacterium, Pseudomonas fluorescens. Here the group fo-
cused on the inhibition of extracellular protease, biofilm formation, as
well as swimming and swarming motility, all of which were shown to
be inhibited by the administration of trans-cinnamaldehyde. Violacein
production was used as a means of determining the inhibitory action on
QS itself, which was inhibited in a concentration-dependent manner by
a maximum of 51.03% at the highest concentration of cinnamaldehyde
examined of 0.1 μL/mL. Though cinnamaldehyde exhibited anti-QS
activity, it was shown not to affect the production of AHLs (N-acylho-
moserine lactones) by P. fluorescens using GC–MS in concentrations up
to 0.1 μL/mL. This was deemed surprising by the authors as AHLs are
associated with QS and its ability to control virulence factors. They
rationalized these results by suggesting that cinnamaldehyde acts as an
AHL antagonist, modifying or inhibiting QS by preventing AHL binding
to their receptors. Additionally, and in agreement with previous re-
ports, the LuxR-type protein of this bacterium was implicated as a
possible mechanism of action in terms of its inhibition of QS using
molecular docking analysis [99].
4.3.4. Anti-quorum sensing effect of trans-cinnamaldehyde and its
derivatives on Streptococcus pyogenes
Cinnamaldehyde along with synthetic 2-nitrocinnamaldehyde
(Fig. 1, structure 18), 4-nitrocinnamaldehyde and 4-dimethylamino-
cinnamaldehyde (Fig. 5, structures 29 & 30) have also been evaluated
for their inhibition of LuxS, including in Streptococcus pyogenes. Here,
Shafreen et al. [102] employed molecular modelling, docking, dy-
namics, and free-energy calculations as part of their study. LuxS is an
important protein, being highly conserved and prevalent in an array of
bacteria [108], and is involved in the synthesis of AI-2 signalling mo-
lecules which facilitate intraspecies and interspecies QS [102]. Hence,
LuxS represents a promising target for antipathogenic agents and the
results of quantitative polymerase chain reaction (qPCR) analysis in a
study by Shafreen et al. [102] showed that the transcripts treated with
cinnamaldehydes at their respective biofilm inhibitory concentrations
showed reduced LuxS expression. In the case of the untreated control, a
normalized signal intensity of 5.00 was recorded, which was reduced to
less than 0.5 after administration of 200 μM/mL 2-ni-
trocinnaamldehyde and to approximately 0.5 with 300 μM/mL 4-di-
methylaminocinnamldehyde. The normalized signal intensity after 4-
nitrocinnamaldehyde administration of 250 μM/mL was also reduced
but to a lesser extent to 1.00. The lowest inhibition was recorded after
300 μmol/mL cinnamaldehyde administration, which reduced the LuxS
expression normalized signal intensity to approximately 1.50. Overall,
the data generated supported the potential use of cinnamaldehyde and
its derivatives against QS-mediated infections caused by S. pyogenes
[102].
4.3.5. Anti-quorum sensing effect of trans-cinnamaldehyde and its
derivatives on Cronobacter sakazakii
Amalarajou et al. [100] found, using reverse transcription (RT)-
qPCR, that trans-cinnamaldehyde was able to significantly down-
regulate the expression of eight genes that have previously been linked
to biofilm formation in Cronobacter sakazakii. In this study, bcsA and
luxR were shown to be the most-downregulated by 20.83 fold and 10.42
fold respectively, after exposure to 560 μM trans-cinnamaldehyde. This
compares to other genes that were downregulated by a maximum of
1.72 fold after treatment with trans-cinnamaldehyde at the same con-
centration (in the case of fliD). Interestingly, these genes are also linked
to the QS ability of C. sakazakii [100], showing how the mechanisms of
action exhibited by trans-cinnamaldehyde and its derivatives in dif-
ferent bacteria can overlap.
4.4. Cell constituent release and loss of cell membrane integrity
In their recent review on essential oils as antimicrobials in foods,
Rao et al. [109] discussed how the disruption of the cell membrane
permeability inactivates the bacteria by facilitating the infiltration of
ions and organic molecules from outside the cell. This eventually leads
to the loss of membrane integrity, which is critical for microbial sur-
vival [109]. Additionally, when the cell membrane is disrupted some of
the intracellular cell constituents are released, and the monitoring of
this release can serve as a means of evaluating the effectiveness of
antimicrobial agents, as well as giving valuable insight into its me-
chanism of action [109,110]. In this review, these studies have broadly
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been divided into two sections, one where all discussed reports involved
E. coli and one where all discussed reports involved Staphylococcus spp.
In some cases, authors have presented reports on the use of both E.coli
and Staphylococcus spp. under the same experimental conditions. In this
review, such reports involving both of these bacteria have been dis-
cussed in the Staphylococcus spp. section 4.4.2.
4.4.1. Cell membrane integrity studies involving E. coli
The release of cell constituents can be experimentally monitored in
various ways. One such method is to monitor the release of microbial
cell constituents by measuring the UV-absorbance of cell cultures at
260 nm, which is the wavelength at which materials such as proteins
and nucleic absorb [111,112]. Proteins and nucleic acids are present
throughout the membrane and cytoplasm of the bacterial cells. Proteins
facilitate key structural functions, while nucleic acids carry unique
genetic information, and both are involved in critical processes such as
translation, transcription, and DNA replication [110]. This approach
has been used by Oussalah et al. [113] to measure the release of cell
constituents from E. coli O157:H7 as well as and L. monocytogenes after
treatment with Chinese cinnamon, the major component of which is
cinnamaldehyde. A significant release of cell constituents was recorded
across all concentrations of Chinese cinnamon administered, the
highest being observed at 0.1% v/v at which the OD260nm recorded
increased by approximately 4-fold for both bacteria. The release of
cellular constituents was also observed to increase with increasing
concentration of Chinese cinnamon essential oil [113].
The monitoring of intracellular pH of cells after exposure to anti-
microbial agents is also indicative of cell membrane permeabilization
[113]. Intracellular pH is a vital parameter for the regulation of many
cellular processes, including DNA transcription, protein synthesis, and
enzyme activity [114]. Oussulah et al. [113] also showed that Chinese
cinnamon oil significantly reduced the intracellular pH of E. coli
O157:H7 and also L. monocytogenes. With respect to E. coli O157:H7, the
intracellular pH of cells decreased significantly on increasing Chinese
cinnamon oil concentration, while this effect was less pronounced with
regard to L. monocytogenes cells. Untreated E. coli cells had an in-
tracellular pH of 7.25, which decreased to 5.16 on administration of
0.025% v/v Chinese cinnamon oil. The intracellular pH decreased
further with increasing concentration of the Chinese cinnamon oil to
5.07 and 4.87, at 0.05% v/v and 0.1% v/v respectively. For L. mono-
cytogenes, a concentration of 0.025% v/v, 0.05% v/v, and 0.1% v/v of
Chinese cinnamon oil decreased the intracellular pH from 6.23 to 5.34,
to 5.12, and to 5.13 respectively. Therefore, the change in intracellular
pH caused by Chinese cinnamon oil was greater for E. coli O157:H7
than L. monocytogenes. In both cases, the authors suggest that the effect
of Chinese cinnamon oil on the intracellular pH was indicative of its
action on the cytoplasmic membrane [113]. Similarly, Turgis et al.
[111] investigated the antimicrobial activity of mustard essential oil on
E. coli O157:H7 and Salmonella typhi and saw that this essential oil also
significantly reduced the intracellular pH in both strains [111].
It is not just the release of 260 nm-absorbing materials that is in-
dicative of bacterial cell membrane integrity. A number of other ma-
terials are affected as a result of the permeabilization of cell mem-
branes. Hossain et al. [115] utilized an automated HS-SPME technique
coupled with GC–MS in order to identify, and in part quantify, the
metabolites released as a result of administration of cinnamaldehyde to
E. coli BL21 cells. Approximately 25 different compounds such as in-
dole, alkanes, and organic acids were observed after the addition of 2 g/
L cinnamaldehyde [115]. In another study, Mousavi et al. [116] used a
SPME−LC−MS platform to evaluate the changes induced by different
doses of cinnamaldehyde in different stages of E. coli growth and found
that compounds related to the TCA cycle, fatty acids, glycolysis, amino
acids metabolism, cell membrane, and protein synthesis were all af-
fected by cinnamaldehyde. The results indicated that cinnamaldehyde,
at a concentration of 100mg/L, interacts with the membrane and the
proteins embedded inside. At a higher concentration of 2000mg/L,
cinnamaldehyde was found to diffuse inside the cell affecting the cy-
toplasmic enzymes and transcriptome, and disrupting the membrane
leading to cell death [116].
In 2015, Yap et al. [107] proposed that the main mode of action of
Cinnamomum verum bark essential oil against a multi-drug resistant E.
coli strain is through the disruption of the bacterial membrane both at
lethal and sublethal concentrations. This was based on evidence gained,
for example, through zeta potential measurements as a means of
monitoring the bacterial surface charge before and after Cinnamomum
verum bark essential oil treatment. The untreated E. coli J53 R1 sample
had a negative surface charge of −15mV, whereas treatment with
0.02% cinnamon bark essential oil saw this reduce to below −13mV.
Here the authors propose that irreversible damage occurs as a result of
acidifying and denaturing the proteins associated with the cell mem-
brane, which in turn is caused by the accumulation of essential oil
components [107].
Analysis of electrical conductivity in bacterial suspensions is also
indicative of the action of antibacterial agents on the cell membrane.
The bacterial plasma membrane facilitates the passage of small ions
such as K+ and Na+, which are necessary electrolytes that enable cell
membrane functions and facilitates normal enzymatic activity [117].
Maintenance of ion homeostasis is an important aspect in maintaining
the energy status of the cell and it is crucial to membrane-coupled
energy-dependent processes including regulation of metabolism, solute
transport, control of turgor pressure, and mobility [118]. Therefore,
even relatively minor alterations to the structure of membranes and
membrane integrity can have a detrimental effect on cell metabolism
and consequently lead to cell death [118]. He et al. [119] monitored
the relative electrical conductivity of E. coli suspensions after treatment
with varying concentrations of isolated cinnamaldehyde and observed a
significant increase in these values post treatment. The group recorded
relative electric conductivity values for E. coli suspensions, which in-
dicate the change of permeability for the E. coli cells, of
35.537 ± 0.242% after exposure to 0.31 g/L cinnamaldehyde for
2.5 h. This group note that the conductivity values increased with
longer incubation times, thus implying an increased in the permeabi-
lization of the cell membrane over time and with higher concentrations
of cinnamaldehyde [119]. Additional results obtained by this group
suggested that cinnamaldehyde not only permeabilises the cell mem-
brane of E. coli cells but also oxidizes it [119]. One such way of mea-
suring this is by analysis of malondialdehyde content. Malondialdehyde
is normally generated as a by-product during the oxidation of cell
membrane, and its content reflects the degree of peroxidation of cell
membrane lipid. The malondialdehyde content in this experiment was
observed to increase with increasing cinnamaldehyde concentration
and increasing treatment time. For example, the content of mal-
ondialdehyde obtained from the control was 0.435 ± 0.051 nmol/
mgprot after 2 h, and it increased to 2.322 ± 0.154 and
2.580 ± 0.256 nmol/mgprot when E. coli was treated with 0.2325 g/L
and 0.31 g/L cinnamaldehyde respectively [119]. Superoxide dismutase
(SOD) content was also monitored. SODs are enzymes that play a cri-
tical role in metabolizing O2•−, preventing oxidizing chain reactions
that cause extensive damage, and are involved in such activities as
preventing the formation of reactive oxygen species like hydrogen
peroxide [120]. In this experiment, the total SOD activity without
cinnamaldehyde treatment was 95.718 ± 0.090 U/mgprot after 1 h,
which increased to 108.460 ± 0.298 and 113.192 ± 1.469 U/mgprot
with treatments of 0.2325 g/L and 0.31 g/L cinnamaldehyde respec-
tively. The authors subsequently suggested that cinnamaldehyde oxi-
dizes the unsaturated fatty acids of the cell membrane, causing a larger
number of active oxygen radicals to be generated, which in turn causes
an increase in SOD activity to resist this harm [119]. The above reports
indicate that treatment with cinnamaldehyde can result in a permea-
bilized cell membrane and that such membrane permeabilization has a
number of effects that can be monitored experimentally. In 2019, Doyle
et al. [129] reported the effect of trans-cinnamaldehyde and some
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derivatives, specifically p-methoxycinnamaldehyde and p-bromocinna-
maldehyde, on cell membrane permeability. This study examined the
bacteriostatic activity of fifteen cinnamaldehyde derivatives against E.
coli as well as S. aureus, and found that p-bromocinnamaldehyde ex-
hibited the highest activity against both bacteria. In order to explore the
relationship between bacteriostatic activity and cell wall/membrane
leakage, a S. aureus or E. coli culture was monitored after 2-, 4- and 6-
hours incubation with each cinnamaldehyde, where results were ex-
pressed in terms of protein and amino acid leakage. The amount of
leakage observed was very different across the three cinnamaldehydes
examined. For both bacteria, trans-cinnamaldehyde caused the highest
leakage of amino acids and proteins, though did not exhibit the greatest
bacteriostatic activity of the derivatives examined. Thus bacteriostatic
activity did not directly correlate with an ability to induce leakage,
suggesting that while cinnamaldehydes may be capable of interacting
with the cell wall of both bacteria it may not be the primary anti-
bacterial mechanism of action.
4.4.2. Cell membrane integrity studies involving Staphylococcus spp.
Shen et al. [121] studied the mechanism of action of cinnamalde-
hyde on S. aureus and E. coli by measuring the UV-absorbance of cell
cultures at 260 nm and similarly observed the significant release of
260 nm absorbing materials from both strains. This occurred quickly
after they were exposed to cinnamaldehyde and reached a plateau after
2 and 4 h, respectively. The absorption values, at 4 h, for the E. coli
treated with 0.31mg/mL cinnamaldehyde was 3.55, which is con-
siderably higher than the control of approximately 0.1 at the same
timepoint. The absorption values, at 2 h, for the S. aureus treated with
0.31mg/mL cinnamaldehyde was 3.00, which was also considerably
higher than the control of approximately 0.25 at the same timepoint
[121].
Kwon et al. [13] also measured the UV-absorbance of cell cultures at
260 nm. This group noted the significant leakage of proteins by S.
aureus, but not B. cereus, over a 120min incubation period after ex-
posure to cinnamaldehyde, and used the Bradford method to investigate
this. Protein leakage was recorded as over 9 μg/mL after exposure to
0.4 mL/L cinnamaldehyde after 120min of incubation. This was ap-
proximately 3 μg/mL higher than the control. In addition, the protein
leakage from S. aureus was observed to increase gradually during the
120min incubation period [13].
In their 2015 publication, Shen et al. [121] also monitored β-ga-
lactosidase activity in S. aureus, as well as E. coli, so as to evaluate inner
membrane permeability after exposure to cinnamaldehyde. β-Galacto-
sidase is an example of an intramembranous material that would not be
leaked unless the cell membrane is damaged. Therefore, how effective
cinnamaldehyde is at permeabilizing the inner membranes of E. coli and
S. aureus could be determined by detecting cytoplasmic β-galactosidase
in the bacterial suspension. To do this, Shen et al. assessed the hydro-
lysis of the substrate ONPG (o-nitrophenyl galactopyranoside), which
when hydrolysed by β-galactosidase produces a coloured product that
can be detected spectrophotometrically at 420 nm. The group found
that β-galactosidase activity increased as the cinnamaldehyde con-
centration was increased, and thus it could be suggested that the level
of inner membrane permeability caused by treatment with cinna-
maldehyde is dependent on its concentration. The β-galactosidase ac-
tivity of E. coli cells treated with 0.31mg/mL cinnamaldehyde at 2 h
was 0.538932 ± 0.000577 U/mL, compared to the control of ap-
proximately 0.42 U/mL at the same timepoint. The β-galactosidase
activity of S. aureus cells treated with 0.31mg/mL of trans-cinna-
maldehyde at 1 h was 0.344472 ± 0.000000 U/mL, compared to the
control of approximately 0.25 U/mL at the same timepoint [121].
Shen et al. [121] also analyzed the electrical conductivity values of
S. aureus and E. coli suspensions after exposure to cinnamaldehyde and
observed that both strains showed higher conductivity values after
administration of cinnamaldehyde than that of the control group. The
group also noted that this effect increased with increasing
cinnamaldehyde concentration, with the exception of one concentra-
tion. This rapid rise trend was observed in both strains, where the
conductivity values of S. aureus increased significantly at the 0–1 h
timepoint. A similar significant increase occurred for E. coli cells, but at
a slightly later 0–2 h timepoint, in agreement to that concluded by He
et al [119] in section 4.4.1. The conductivity value of E. coli treated
with 0.31mg/mL cinnamaldehyde was 9.673 ± 0.011547 μs/cm at
the two-hour timepoint, compared to the control conductivity value of
approximately 8.6 μs/cm. For S. aureus, treatment with 0.31mg/mL
cinnamaldehyde generated a conductivity value of approximately
11.25 ± 0.005568 μs/cm at the 1-h timepoint, which compares to the
control value of approximately 9.7 μs/cm. As a result, the authors
suggest that the higher the cinnamaldehyde concentration, then the
greater the extent of damage to the bacterial cell membrane [121].
These findings were in agreement with with those made by Zhang
et al. [110], who analyzed changes in relative electric conductivity after
exposure of S. aureus and E. coli cells to cinnamon essential oil. The
group observed a rapid increase in the electric conductivity of sus-
pensions of both bacteria upon treatment, corresponding to the leakage
of small electrolytes. Here the relative electric conductivity values,
which was used to express the change in permeability, obtained for E.
coli and S. aureus reached 60% and 79.4% respectively at the seven-
hour timepoint after exposure to 4.0mg/mL and 2.0mg/mL cinnamon
essential oil respectively. This was relative to the control which reached
a relative conductivity value of less than 5% for E. coli and 10% for S.
aureus respectively. The authors note that their results indicate that
treatment with cinnamon essential oil causes an increase in the per-
meability of cell membrane, causing cellular leakage [110]. This is in
agreement with the findings of Albano et al. [101] who studied the
effect of trans-cinnamaldehyde on S. epidermis ATCC 35984 cell mem-
brane permeability. It was observed that the administration of 300 μg/
mL cinnamaldehyde resulted in an increase of relative electric con-
ductivity of 41% after incubation for 8 h compared to the control where
less than 5% relative electric conductivity was observed. This therefore
indicated that trans-cinnamaldehyde was capable of permeabilizing the
cell membrane, and this effect was observed to increase with longer
incubation times and higher cinnamaldehyde concentrations [101].
4.5. Morphological changes induced by exposure to cinnamaldehyde
The morphological changes that occur in bacterial cells as a result of
exposure to trans-cinnamaldehyde has been investigated across a range
of bacteria. For example, Nazarro et al. [10] have described a number
of bacteria that trans-cinnamaldehyde is capable of eliciting morpho-
logical changes on, including S. typhimurium, Pseudomonas spp., and
Brochothrix thermosphacta [10]. For the most part, the morphological
changes that occur as a result of trans-cinnamaldehyde exposure has
been analyzed by scanning or transmission electron microscopy (SEM
or TEM respectively), and will be discussed in the following sections. To
the best of our knowledge, there are no studies investigating the
changes to bacterial cell morphology induced by exposure to trans-
cinnamaldehyde derivatives.
4.5.1. Morphological changes induced with S. aureus and E. coli
Shen et al. [121] employed SEM to analyze the effect of cinna-
maldehyde on the membranes of S. aureus ATCC3101 and E. coli
ATCC8735 cells at the minimum inhibitory concentration (MIC)
(0.31 mg/mL in both cases). The group observed a number of changes
in both cells after treatment with cinnamaldehyde for 6–8 h, noting in
particular the effects on S. aureus cells including splitting of some cells,
development of deep wrinkles and distortion, deterioration of the cell
wall, and extensive cell lysis. The external structure of E. coli was also
affected but to a lesser extent, namely a rough cell membrane with
some particulate matter and some swelling was observed after treat-
ment with trans-cinnamaldehyde at its MIC. The authors note that the
ability to induce these morphological changes is likely as a result of
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cinnamaldehyde being capable of penetrating the cell envelope and
consequently alter its structure [121].
Shen et al. [121] used TEM to observe a number of changes with
respect to E. coli after treatment with cinnamaldehyde at its MIC for
6–8 h, including the separation of cytoplasmic membrane from the cell
wall, cell wall and cell membrane lysis, cytoplasmic content leakage,
polarization and condensation, as well as distortion of the cell. Similar
changes where observed with respect to S. aureus, notably the disin-
tegration of the cell as well as leakage and polarization of cytoplasmic
content, which was observed after exposure of cells to cinnamaldehyde
at its MIC. The authors note that these effects correlate with the ability
of hydrocarbons, such as cinnamaldehyde, to interact with hydrophobic
structures such as bacterial membranes. Importantly, the TEM results
show that cinnamaldehyde targets different parts of the cell and so, the
antibacterial activity exhibited by cinnamaldehyde is most likely not as
a result of one specific mechanism [121].
4.5.2. Morphological changes induced with S. aureus and B. cereus
Kwon et al. [13] analyzed the morphological changes observed after
exposure of cells to cinnamaldehyde using SEM, investigating B. cereus
ATCC11778 and S. aureus ATCC22954 cells. Conversely to the report by
Shen et al., [121] Kwon et al. report no major differences between
untreated S. aureus cells and those after administration of 0.3mL/L
cinnamaldehyde, but importantly a different S. aureus strain was used
and there was a much shorter incubation time of 1 h before SEM was
applied. However, the morphology of the B. cereus was significantly
changed after exposure to cinnamaldehyde at the same concentration,
with changes such as the elongation of cells, formation of thinner fi-
laments in which there were no separation of cells, and the formation of
incomplete septa between two cells being observed [13].
4.5.3. Morphological changes induced with E. coli and L. monocytogenes
Oussalah et al. [113], again conversely to the report by Shen et al.
[121], showed that after treatment with Chinese cinnamon at 0.05%
(v/v), the appearance of cells of E. coli O157:H7 and L. monocytogenes
was unchanged. Importantly, a different E. coli strain was used com-
pared to that used by Shen et al. [121] and a much shorter incubation
time of 30min was applied in this study before implementation of TEM
analysis. However, the authors note that other results presented in this
study showed evidence of disruption to the cell membrane in both
bacteria, such as an increase in the permeabilization of cells to the dye
phosphotungstic acid (1% (weight/vol), pH 6), as visualized using TEM,
as well as other data already discussed in section 4.4.1 including release
of cellular constituents and changes in intracellular pH [113]. Thus,
while there is conflicting evidence in the literature regarding the exact
morphological changes that trans-cinnamaldehyde administration in-
duces on cells, it is apparent that certain changes, particularly with
respect to those involving the cell membrane, are induced.
4.6. Effect of cinnamaldehydes on ATP levels
Adenosine triphosphate (ATP) is a small molecule of critical im-
portance for a range of organisms. It is generated via respiration and is
used for such cellular functions as storing and supplying energy, en-
zymatic reactions, cell signalling, and many other functions that are
pertinent to the survival, growth, and replication of cells [122]. There is
agreement in the literature on the impact of cinnamaldehyde, whether
isolated or as a major component of Chinese cinnamon oil, on ATP le-
vels. There are numerous reports that detail a significant decrease in the
levels of intracellular ATP, post treatment and without causing an in-
crease in extracellular ATP levels, across a range of bacteria including E.
coli [18,113,123], Salmonella typhimurium [123], Listeria monocytogenes
[14,18,113], and Map (Mycobacterium avium subsp. paratuberculosis)
[124]. Interestingly, trans-cinnamaldehyde has been shown to have no
effect on Lactobacillus sakei at concentrations of up to 0.5M [14]. There
is some disparity however as to what can be concluded from these
results and what the authors suggest in terms of the effect of trans-
cinnamaldehyde has on the bacterial cell membrane. In order to ef-
fectively summarize and review this area of work, the following two
sections will cover reports from 1998 to 2006 and from the more recent
literature of 2006–2019.
4.6.1. Effect of cinnamaldehyde on ATP levels (1998–2006)
Earlier work on understanding the mechanism of action suggested
that trans-cinnamaldehyde did not disrupt the outer membrane of
bacterial cells [18,123]. Helander et al. [123] deduced that trans-cin-
namaldehyde could gain access to the periplasm and to the deeper parts
of the cell without exerting disintegrative effects on the outer mem-
brane. This was based on evidence obtained experimentally by the
authors who noted that even though trans-cinnamaldehyde exhibited
good bioactivity, for example it could inhibit the bioluminescence of P.
leiognathi by around 75% at concentrations as low as approximately
0.12mM, there was a lack of effect on the size of the intracellular ATP
pool during the incubation period at a concentration of 2mM. Ad-
ditionally, exposure of E. coli cells to trans-cinnamaldehyde did not
induce the release of outer membrane-associated material, for example
it did not affect NPN (1-N-phenylnaphthylamine) uptake after 2mM
trans-cinnamaldehyde was administered [123].
Gill and Holley [18] observed that administration of 10mM trans-
cinnamaldehyde to E. coli and 40mM trans-cinnamaldehyde to L.
monocytogenes caused significant decreases in intracellular ATP levels.
Here, the treatment of E. coli cells with dextrose, the control used in this
experiment, had an associated intracellular ATP concentration of ap-
proximately 4400 fmol/μg protein after 20min incubation and was
compared to the intracellular ATP concentration of approximately 1400
fmol/μg protein after the same incubation period and post treatment
with 10mM trans-cinnamaldehyde. However, the group observed no
increase in extracellular ATP concentration experimentally and de-
duced that this occurrence is inconsistent with membrane permeabili-
zation. They hypothesized that ATP inhibition could represent a sec-
ondary factor rather than a primary cause of cell death in this case [18].
Previously, Gill and Holley [14] had hypothesized that trans-cinna-
maldehyde could interact with the cell membrane, causing sufficient
damage to result in the leakage of small ions, thus affecting the proton
motive force, but insufficient damage to result in the leakage of larger
cell components such as ATP. This is how the authors explained that no
increase in extracellular ATP levels were observed experimentally after
exposure of L. monocytogenes cells to 40mM trans-cinnamaldehyde,
though with the same treatment a significant decrease in intracellular
ATP levels was observed. Treatment of L. monocytogenes cells with
glucose, the control used, had an associated intracellular ATP con-
centration of approximately 530 fmol/μg protein after 20min incuba-
tion compared to the intracellular ATP concentration of approximately
50 fmol/μg protein after the same incubation period and post admin-
istration of 40mM trans-cinnamaldehyde. Additionally, the authors
noted that these results are consistent with either inhibition of glucose
import or inhibition of glycolysis [14].
4.6.2. Effect of cinnamaldehyde on ATP levels (2006–2019)
More recent papers postulate that trans-cinnamaldehyde can alter
the integrity of bacterial cell membranes. For example, Oussalah et al.
[113] reported that the administration of Chinese cinnamon essential
oil at its MIC alters the membrane integrity of both E. coli and L.
monocytogenes cells. This was deduced in part on the basis of cinna-
maldehyde's effect on ATP, where a treatment of E. coli O157:H7 cells
with 0.025% (v/v) Chinese cinnamon oil, the lowest concentration
examined, caused a significant decrease in intracellular ATP con-
centration from 1.84 ng/mL to 1.09 ng/mL, and a slight increase in
extracellular ATP concentration from 0.03 ng/mL to 0.05 ng/mL. Si-
milar observations were also made with respect to treatment of L.
monocytogenes with Chinese cinnamon oil. Additionally, its effect on
intracellular pH was monitored, as well as the use of electronic
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microscopy analysis, as previously discussed in sections 4.4.1 and 4.5.3.
Both of which support the hypothesis that trans-cinnamaldehyde affects
the integrity of bacterial cell membranes [113]. Nowotarska et al. [124]
also determined that cinnamaldehyde is capable of disrupting the
bacterial membrane based on evidence gained in part from observation
of the effect of cinnamaldehyde on ATP. Nowotarska et al. noted, in
agreement with previous reports, that cinnamaldehyde significantly
decreased intracellular ATP without affecting the extracellular ATP
concentration of 0.5 nM. The conclusion drawn regarding the ability of
cinnamaldehyde to disrupt the bacterial membrane was also based on
evidence gained from the implementation of monolayer studies using a
Langmuir trough apparatus as well analysis of cellular constituents
released after treatment with cinnamaldehyde. For example, the per-
formance of an extracellular phosphate assay on Map cells showed an
increase in extracellular phosphate levels in the presence of cinna-
maldehyde that was concentration- and time-dependent [124].
Silva et al. [103] reported the effect of cinnamaldehyde against
Salmonella Typhimurium ATCC 14028 biofilms and compared the pro-
tein patterns of untreated biofilms versus those after treatment with
624 μg/mL cinnamaldehyde using proteomic analysis. One such protein
whose expression decreased after cinnamaldehyde exposure was ATP
synthase alpha chain protein. This protein is a component of the ATP
synthase protein complex that functions in the bacterial cell to assist in
the production of ATP. Interestingly, though its expression was in-
creased 6.6-fold in the biofilm itself, after exposure to cinnamaldehyde
this protein was not expressed at all. [103] Thus, ATP synthase alpha
chain protein is potentially a target of cinnamaldehyde in bacterial cells
and causes the reduction in ATP levels that have been experimentally
observed.
4.7. Effect of cinnamaldehydes on ATPase
ATPases catalyse the hydrolysis of ATP to ADP. There are different
types of ATPases which serve important cellular functions. For example,
Na+/K+ ATPase, a P-type transport ATPase, is responsible for the
generation of ionic transmembrane gradients that are important in such
cellular activities such as active transport processes, and the main-
tenance of intracellular pH and ion homeostasis [125]. Transport AT-
Pases are a type of ATPase used to transport ions and have common
features; they exist in biological membranes, hydrolyze ATP, and
transport at least one substance across a biological membrane using
energy gained from ATP hydrolysis [126]. Lipophilic compounds, such
as cinnamaldehyde, may indirectly influence the pool of adenine nu-
cleotides, due to the interlinking of the proton motive force and phos-
phate potential via F0F1 ATPases. An example of such an adenine nu-
cleotide is ATP, and its depletion has been observed in several cases
upon treatment with cinnamaldehyde, as discussed above with respect
to intracellular ATP levels. The observation that lipophilic compounds
stimulate the activity of proton and/or ion-translocating ATPases may
originate from the removal of the proton motive force, limiting ATP
hydrolysis [127]. Thus, if the normal activity of ATPases is interrupted,
the electrolyte balance of the cell will be affected, which has a direct
effect on homeostasis of the cell and results in a decrease in ATP levels
[125]. This could possibly even result in the occurrence of cell death if
cellular respiration is affected [109].
The effect of trans-cinnamaldehyde on bacterial ATPases has been
investigated as a possible the mechanism of action for its antibacterial
properties. Gill and Holley [128] investigated the ability of trans-cin-
namaldehyde to inhibit membrane bound ATPases of E. coli and L.
monocytogenes. Increasing concentrations of trans-cinnamaldehyde led
to increasingly greater inhibition of ATPase activity in E. coli cell
membranes. As the concentration of trans-cinnamaldehyde increased
from 0.1mM to 10mM, the corresponding inhibition of ATPase activity
was recorded as less than 10% to over 85% respectively. L. mono-
cytogenes ATPase activity was also shown to be significantly inhibited
by trans-cinnamaldehyde, but only at the highest concentration of trans-
cinnamaldehyde administered of 10mM [128]. This agrees with the
suggestion made by Nazarro et al. [10] in their review paper, that trans-
cinnamaldehyde is an ATPase-inhibitor in bacterial cells. Gill and
Holley [128] noted that the observed inhibition of ATPase activity may
be due to the non-specific inhibition of membrane-bound or embedded
enzymes [128]. Such enzymes not only include ATPases, but also
transport proteins, transferases, various oxidreductases, and signal-
transducing enzymes [127]. This non-specific inhibition may be caused
by the ability of small hydrophobic molecules, such as trans-cinna-
maldehyde, to induce changes in protein conformation as a result of
hydrophobic interactions [128]. Gill and Holley [14] previously noted
that although the inhibition of energy generation processes may not be
the sole mechanism of action of trans-cinnamaldehyde or similar mo-
lecules, they are the most important. They attribute this to the cells
being unable to reproduce or alter their metabolism, in order to adapt
to the antimicrobial challenge they are exposed to, as they are no longer
capable of generating energy [14].
There are various enzymes in bacterial membranes with associated
ATPase activity. Examples include F0F1 ATPase, which as discussed
above is involved in generating ATP and regulating cellular pH.
Although not a bacterial cell study, Usta et al. [125] reported some
interesting ATPase results using trans-cinnamaldehyde and rat liver
ATPases. This group investigated the effect of trans-cinnamaldehyde on
different types of rate liver ATPases, namely P-type Na+/K+ ATPase
and CPx-type Cu2+ ATPase. Both ATPases were inhibited by trans-
cinnamaldehyde in a concentration-dependent manner, where a 50%
inhibition of Na+/K+ ATPase activity was recorded at approximately
4.7 mM and a 50% inhibition of CPx-type Cu2+ ATPase at 0.94mM. F-
type mitochondrial F0F1 ATPase was conversely stimulated by 0.37 MM
trans-cinnamaldehyde. As such, all three ATPases represent possible
intracellular targets for trans-cinnamaldehyde on the basis of this study
[125]. Although the ATPases investigated in this study were not bac-
terial, it possible that trans-cinnamaldehyde could interact with bac-
terial P-, F- and CPx- classes of ATPases in a similar manner.
To the best of our knowledge, no studies that have been conducted
investigating the effect of trans-cinnamaldehyde derivatives on bac-
terial ATP levels or ATPases. Shreaz et al. [61] studied the effect of
cinnamaldehyde along with two if its natural derivatives, coniferyl al-
dehyde and sinapaldehyde (Fig. 1, structure 15 & 16), against 65 strains
of Candida and all three compounds were found to be effective against
all Candida strains tested. MICs of cinnamaldehyde, coniferyl aldehyde,
and sinapaldehyde ranged from 100 to 500 μg/mL, 100 to 300 μg/mL,
and 100 to 200 μg/mL respectively. The authors attribute their activity,
at least in part, to their ability to inhibit plasma membrane-ATPases,
where the inhibition caused by the three cinnamaldehydes at their re-
spective MIC90 concentrations correlated well with that of known
plasma membrane-ATPase inhibitors N,N′-dicyclohexylcarbodiimide
(100 μM) and diethylstilbestrol (10 μM) [61].
5. Conclusion
In this review, we have presented studies where the antibacterial
activity of the naturally occurring compound trans-cinnamaldehyde and
its derivatives have been investigated. This work highlights studies
where the antibacterial mechanisms of action of trans-cinnamaldehyde,
and in some cases that of cinnamaldehyde derivatives, have been ex-
plored. At a time when antibiotic resistance is a global threat, there is
an urgent need for alternative antibacterial agents than those currently
available. Trans-Cinnamaldehyde can be considered a promising re-
search prospect, in part as an antibacterial agent itself due to its modest
antibacterial activity across a broad scope of bacteria and low asso-
ciated toxicity, but perhaps more significantly as a hit compound from
which other antibacterial agents can be developed, or as a tool to better
understand and develop targets for new antibacterial agents. Some
trans-cinnamaldehyde derivatives that have been synthesized have al-
ready shown improved antibacterial activity relative to trans-
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cinnamaldehyde. These compounds, and their mechanisms of action,
therefore warrant further investigation as potential antibacterial agents
and targets. However, the current knowledge on the antibacterial me-
chanisms of action of these compounds, cinnamaldehyde derivatives in
particular, is limited. As such, further studies should be undertaken in
order to optimise the potential of these compounds and targets. This
review, summarizing the major contributions in this area to date, will
aid in the future development of cinnamaldehyde-based antibacterial
agents or new agents seeking to exploit similar mechanisms of action.
Preliminary results obtained in this area give much promise to future
investigations and it is hoped that this review may potentially help
contribute to the discovery of new agents with real-world applications
in clinical and/or agricultural settings. It is also anticipated that those
conducting important studies in other areas of cinnamaldehyde appli-
cation will find this review useful in terms of summarizing some of the
potential biological roles and mechanisms of action for cinnamalde-
hydes.
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